PL2001445T3 - Farmaceutyczne sferoidy - Google Patents

Farmaceutyczne sferoidy

Info

Publication number
PL2001445T3
PL2001445T3 PL07733554T PL07733554T PL2001445T3 PL 2001445 T3 PL2001445 T3 PL 2001445T3 PL 07733554 T PL07733554 T PL 07733554T PL 07733554 T PL07733554 T PL 07733554T PL 2001445 T3 PL2001445 T3 PL 2001445T3
Authority
PL
Poland
Prior art keywords
spheroids
pharmaceutical
pharmaceutical spheroids
Prior art date
Application number
PL07733554T
Other languages
English (en)
Inventor
Helen Kathleen Danagher
Geoffrey Gerard Hayes
Hassan Mohammad
Malcolm Walden
Jonathon Oliver Whitehouse
Original Assignee
Euro Celtique Sa
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Priority claimed from GB0605271A external-priority patent/GB0605271D0/en
Priority claimed from GB0605542A external-priority patent/GB0605542D0/en
Priority claimed from GB0617272A external-priority patent/GB0617272D0/en
Application filed by Euro Celtique Sa filed Critical Euro Celtique Sa
Publication of PL2001445T3 publication Critical patent/PL2001445T3/pl

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/14—Particulate form, e.g. powders, Processes for size reducing of pure drugs or the resulting products, Pure drug nanoparticles
    • A61K9/16—Agglomerates; Granulates; Microbeadlets ; Microspheres; Pellets; Solid products obtained by spray drying, spray freeze drying, spray congealing,(multiple) emulsion solvent evaporation or extraction
    • A61K9/1605—Excipients; Inactive ingredients
    • A61K9/1617—Organic compounds, e.g. phospholipids, fats
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/435—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with one nitrogen as the only ring hetero atom
    • A61K31/47—Quinolines; Isoquinolines
    • A61K31/485—Morphinan derivatives, e.g. morphine, codeine
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/14—Particulate form, e.g. powders, Processes for size reducing of pure drugs or the resulting products, Pure drug nanoparticles
    • A61K9/16—Agglomerates; Granulates; Microbeadlets ; Microspheres; Pellets; Solid products obtained by spray drying, spray freeze drying, spray congealing,(multiple) emulsion solvent evaporation or extraction
    • A61K9/1605—Excipients; Inactive ingredients
    • A61K9/1629—Organic macromolecular compounds
    • A61K9/1635—Organic macromolecular compounds obtained by reactions only involving carbon-to-carbon unsaturated bonds, e.g. polyvinyl pyrrolidone, poly(meth)acrylates
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/48—Preparations in capsules, e.g. of gelatin, of chocolate
    • A61K9/50—Microcapsules having a gas, liquid or semi-solid filling; Solid microparticles or pellets surrounded by a distinct coating layer, e.g. coated microspheres, coated drug crystals
    • A61K9/5005—Wall or coating material
    • A61K9/5021—Organic macromolecular compounds
    • A61K9/5036—Polysaccharides, e.g. gums, alginate; Cyclodextrin
    • A61K9/5042—Cellulose; Cellulose derivatives, e.g. phthalate or acetate succinate esters of hydroxypropyl methylcellulose
    • A61K9/5047—Cellulose ethers containing no ester groups, e.g. hydroxypropyl methylcellulose
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A61P25/04—Centrally acting analgesics, e.g. opioids
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Engineering & Computer Science (AREA)
  • General Health & Medical Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Animal Behavior & Ethology (AREA)
  • Chemical & Material Sciences (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Epidemiology (AREA)
  • Emergency Medicine (AREA)
  • Molecular Biology (AREA)
  • Biophysics (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • General Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Biomedical Technology (AREA)
  • Neurology (AREA)
  • Neurosurgery (AREA)
  • Pain & Pain Management (AREA)
  • Medicinal Preparation (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
PL07733554T 2006-03-16 2007-03-16 Farmaceutyczne sferoidy PL2001445T3 (pl)

Applications Claiming Priority (5)

Application Number Priority Date Filing Date Title
GB0605271A GB0605271D0 (en) 2006-03-16 2006-03-16 Pharmaceutical spheroids
GB0605542A GB0605542D0 (en) 2006-03-20 2006-03-20 Pharmaceutical Spheroids
GB0617272A GB0617272D0 (en) 2006-09-04 2006-09-04 Pharmaceutical spheroids
PCT/GB2007/050129 WO2007105016A1 (en) 2006-03-16 2007-03-16 Pharmaceutical spheroids
EP07733554.5A EP2001445B1 (en) 2006-03-16 2007-03-16 Pharmaceutical spheroids

Publications (1)

Publication Number Publication Date
PL2001445T3 true PL2001445T3 (pl) 2015-06-30

Family

ID=38191129

Family Applications (1)

Application Number Title Priority Date Filing Date
PL07733554T PL2001445T3 (pl) 2006-03-16 2007-03-16 Farmaceutyczne sferoidy

Country Status (13)

Country Link
US (1) US9034373B2 (pl)
EP (1) EP2001445B1 (pl)
JP (2) JP5443768B2 (pl)
CY (1) CY1115770T1 (pl)
DK (1) DK2001445T3 (pl)
ES (1) ES2516693T3 (pl)
HR (1) HRP20141001T1 (pl)
ME (1) ME02135B (pl)
PL (1) PL2001445T3 (pl)
PT (1) PT2001445E (pl)
RS (1) RS53624B1 (pl)
SI (1) SI2001445T1 (pl)
WO (1) WO2007105016A1 (pl)

Families Citing this family (4)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
PT2001445E (pt) * 2006-03-16 2014-10-24 Euro Celtique Sa Esferoides farmacêuticos
AT511581A1 (de) 2011-05-26 2012-12-15 G L Pharma Gmbh Orale retardierende formulierung
FR3080278B1 (fr) * 2018-04-11 2021-04-30 Ghs Patents Ltd Procede de fabrication d'un spheroide de cannabidiol
WO2021158957A1 (en) 2020-02-05 2021-08-12 Summit Biosciences Inc. Drug products for intranasal administration and uses thereof

Family Cites Families (20)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
FR2471784A1 (fr) 1979-12-21 1981-06-26 Roussel Uclaf Medicaments antiarythmiques a action prolongee dont le principe actif est le a/2-/bis (1-methylethyl) amino/ethyl/-a-phenyl-2-pyridine acetamide ou ses sels, ainsi que le procede de preparation de ces nouveaux medicaments et compositions les renfermant
GB8626098D0 (en) * 1986-10-31 1986-12-03 Euro Celtique Sa Controlled release hydromorphone composition
SE9200858L (sv) * 1992-03-20 1993-09-21 Kabi Pharmacia Ab Metod för framställning av pellets med fördröjd frisättning
EP0654263B1 (en) * 1993-11-23 2002-01-23 Euro-Celtique S.A. Method for preparing a sustained release composition
DE4415921A1 (de) * 1994-05-05 1995-11-09 Bayerische Motoren Werke Ag Vorrichtung zum Dämpfen von Schwingungen in einer Getriebeschaltvorrichtung für Fahrzeuge
WO1995033446A1 (en) 1994-06-03 1995-12-14 The Procter & Gamble Company Fast dissolving dosage forms
US5458823A (en) * 1994-10-28 1995-10-17 Fuisz Technologies Ltd. Method and apparatus for spinning feedstock material
JP3893439B2 (ja) * 1994-12-19 2007-03-14 第一製薬株式会社 徐放性粒状製剤およびその製造方法
AU694655B2 (en) 1995-05-02 1998-07-23 Taisho Pharmaceutical Co., Ltd. Composition for oral administration
JP5042447B2 (ja) * 1995-07-21 2012-10-03 第一三共株式会社 混合製剤
ES2233971T3 (es) 1995-07-21 2005-06-16 Daiichi Pharmaceutical Co., Ltd. Procedimiento de produccion de una preparacion granular.
US5851454A (en) * 1997-06-13 1998-12-22 Fuisz Technologies, Ltd. Spinner head having flow restricting inserts
RS49982B (sr) * 1997-09-17 2008-09-29 Euro-Celtique S.A., Sinergistička analgetička kombinacija analgetičkog opijata i inhibitora ciklooksigenaze-2
US6117452A (en) 1998-08-12 2000-09-12 Fuisz Technologies Ltd. Fatty ester combinations
CA2367373C (en) 1999-03-17 2011-09-20 Daiichi Pharmaceutical Co., Ltd. Medicinal compositions
US6419954B1 (en) * 2000-05-19 2002-07-16 Yamanouchi Pharmaceutical Co., Ltd. Tablets and methods for modified release of hydrophilic and other active agents
CN1491104A (zh) * 2001-02-13 2004-04-21 新型改进释放制剂
EP1585501A4 (en) * 2003-01-23 2007-04-25 Amorepacific Corp PREPARATIONS OF DELAYED RELEASE AND METHOD OF MANUFACTURING THEREOF
US20060251724A1 (en) * 2003-05-06 2006-11-09 Farrell Thomas P Method for preparing thermoformed compositions containing acrylic polymer binders, pharmaceutical dosage forms and methods of preparing the same
PT2001445E (pt) * 2006-03-16 2014-10-24 Euro Celtique Sa Esferoides farmacêuticos

Also Published As

Publication number Publication date
HRP20141001T1 (hr) 2014-12-05
EP2001445A1 (en) 2008-12-17
JP5443768B2 (ja) 2014-03-19
US20100047337A1 (en) 2010-02-25
SI2001445T1 (sl) 2015-02-27
WO2007105016A1 (en) 2007-09-20
EP2001445B1 (en) 2014-07-23
CY1115770T1 (el) 2017-01-25
ES2516693T3 (es) 2014-10-31
RS53624B1 (sr) 2015-04-30
US9034373B2 (en) 2015-05-19
DK2001445T3 (da) 2014-10-27
PT2001445E (pt) 2014-10-24
JP2014088363A (ja) 2014-05-15
ME02135B (me) 2015-04-30
JP2009530258A (ja) 2009-08-27

Similar Documents

Publication Publication Date Title
IL194762A0 (en) Pharmaceutical compounds
ZA200809479B (en) New pharmaceutical compounds
GB0608820D0 (en) Pharmaceutical compounds
ZA200806318B (en) Drug combinations
GB0614586D0 (en) Pharmaceutical Formulation
IL197883A0 (en) Combination drug
SI2001445T1 (sl) Farmacevtski sferoidi
GB0625783D0 (en) Medicament
GB0608176D0 (en) Pharmaceutical Compounds
GB0600528D0 (en) Drug detector
GB0608184D0 (en) Pharmaceutical compounds
GB0615064D0 (en) Medicament
GB0717882D0 (en) Novel pharmaceutical
GB0608175D0 (en) Pharmaceutical Compounds
GB0608264D0 (en) Pharmaceutical compounds
GB0608996D0 (en) Drug counter
GB0615814D0 (en) Medicament
ZA200708369B (en) Medicament
GB0605542D0 (en) Pharmaceutical Spheroids
GB0605271D0 (en) Pharmaceutical spheroids
GB0617272D0 (en) Pharmaceutical spheroids
GB0622892D0 (en) Pharmaceutical compounds
GB0625682D0 (en) Pharmaceutical compounds
GB0618135D0 (en) Novel pharmaceutical
GB0614457D0 (en) Pharmaceutical Combinations